Skip to main content
Premium Trial:

Request an Annual Quote

Canada and the Netherlands Ink Agreement to Conduct Joint Genomics Research

NEW YORK, Oct. 16 - Genome Canadaand the Netherlands Genomics Initiative said they have signed an agreement to work together on large-scale genomics projects.

 

The two-and-a-half year initial collaboration will seek to promote exchanges between the countries' academic scientists as well as build bridges between biotech and pharmaceutical companies and venture capital firms, according to the organizations.

 

The agreement "will help build on both countries' existing strengths as well as increase cooperation on larger and more difficult genomics projects," Peter Harder, deputy minister of Industry Canada, said in a statement.

 

The first approximately year-long phase of the collaboration will include the organizations spending approximately $100,000 each to bring scientists together and foster discussion of projects to focus on, Anie Perrault, vice president of communications at Genome Canada, told GenomeWeb.

 

The next step will include choosing one to three large-scale genomics programs to fund, said Perrault. The genomics research will most likely be in the fields of health, forestry, agriculture, or fisheries, and may include proteomics, bioinformatics, or functional genomics. Each country will contribute approximately $10 million per project, according to Perrault.

 

Genome Canada, a non profit organization, has invested approximately $290 million in genomics research throughout Canada, according to the organization.

 

The Netherlands Genomics Initiative has a €189 million budget for financing genomics centers and projects over five years.

 

Click here for more information.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.